<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Domenico Memoli</submitter><organism>Homo sapiens</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16473</full_dataset_link><description>AKAP1 is highly expressed in glioblastoma and is required for tumor growth. We therefore analyzed the AKAP1 RNA interactome in glioblastoma cells. Native RNA immunoprecipitation followed by high-throughput sequencing (RIP-Seq) was performed in U87MG cells transiently expressing V5-tagged mouse wild-type AKAP1, as well as deletion mutants lacking either the KH (Δ563–630) or Tudor (Δ709–786) domain, to assess domain-specific RNA binding.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Growth Protocol - The human glioblastoma cell line U87MG was cultured in Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum, L-glutamine, penicillin, streptomycin, and Amphotericin B in a humidified incubater in the presence of 5% CO2.</sample_protocol><sample_protocol>Sample Collection - For each AKAP1-associated RNA immunoprecipitation (RIP) reaction, an anti-V5 antibody was conjugated to sheep anti-mouse IgG–conjugated beads. Protein lysates prepared from U87MG cells transiently transfected with empty vector, wild-type AKAP1, or AKAP1 deletion mutants were incubated with the antibody-conjugated beads. An aliquot of diluted protein lysate was reserved for subsequent RNA extraction as the “input” control. Bead–lysate mixtures were incubated overnight at 4 °C with rotation, followed by four washes with NT2 buffer.</sample_protocol><sample_protocol>Nucleic Acid Extraction - Input samples and washed post-IP reaction beads were resuspended in NT2 buffer and treated with proteinase K to release RNAs from RNA–protein complexes. RNA was then purified using the RNA Clean &amp; Concentrator™-5 Kit (Zymo Research) according to the manufacturer’s instructions.</sample_protocol><sample_protocol>Sequencing - An equimolar pool of libraries at a concentration of 1.2 nM was sequenced on the NovaSeq 6000 platform (Illumina) using 2 × 100 bp paired-end mode.</sample_protocol><sample_protocol>Library Construction - Libraries were prepared using the TruSeq Stranded Total RNA Library Prep Gold kit (Illumina).</sample_protocol><sample_protocol>Sample Treatment - Vectors encoding wild-type or mutant AKAP1 were transiently transfected into U87MG cells using linear polyethylenimine.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Data Transformation - normalization performed using deseq2 default procedure</data_protocol><data_protocol>Sequence Alignment - we used STAR alignment tool using human h38 as reference</data_protocol><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Illumina NovaSeq 6000</instrument_platform><study_type>RIP-seq</study_type><species>Homo sapiens</species><pubmed_authors>Domenico Memoli</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA sequencing–based determination of the RNA interactome of wild-type AKAP1 and its deletion mutants deficient for the KH or Tudor domain.</name><description>AKAP1 is highly expressed in glioblastoma and is required for tumor growth. We therefore analyzed the AKAP1 RNA interactome in glioblastoma cells. Native RNA immunoprecipitation followed by high-throughput sequencing (RIP-Seq) was performed in U87MG cells transiently expressing V5-tagged mouse wild-type AKAP1, as well as deletion mutants lacking either the KH (Δ563–630) or Tudor (Δ709–786) domain, to assess domain-specific RNA binding.</description><dates><release>2026-09-01T00:00:00Z</release><modification>2026-09-01T01:00:38.746Z</modification><creation>2025-12-22T18:55:40.225Z</creation></dates><accession>E-MTAB-16473</accession><cross_references><ENA>ERP187053</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0003789</EFO><EFO>EFO_0005310</EFO><EFO>EFO_0004917</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0004184</EFO><EFO>EFO_0003969</EFO></cross_references></HashMap>